MarketPeel
Insider Trading Intelligence
VL

Vida Ventures Gp Iii, L.l.c.

KYTX
10% OWNER · KYVERNA THERAPEUTICS, INC. · CIK 0001855502
FILING MIX · LIFETIME58%/42%
BUYS
7
SELLS
5
TOTAL VALUE
$10.57M
COMPANIES
2
ACTIVE SINCE
Feb 2024
HOLDINGS NOW
0
AVG SELL PX
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Vida Ventures Gp Iii, L.l.c., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+0.00%-5.61%+0.06%-5.67%-5.67%
14d4+0.00%-7.21%+0.83%-8.04%-8.04%
30d4+50.00%-1.92%+1.92%-3.85%-3.85%
60d4+0.00%-14.38%+3.09%-17.48%-17.48%
90d4+50.00%-15.35%+4.57%-19.92%-19.92%
180d4+50.00%-15.59%+4.97%-20.56%-20.56%
1y4(2 pending)+0.00%-90.21%+22.38%-112.58%-112.58%
2y4(2 pending)+0.00%-74.77%+40.31%-115.09%-115.09%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KYTX · 0 shares · as of Feb 12, 2024
01,130,9812,261,9623,392,9434,523,924SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
FLOW · 7 buys / 5 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LBRX
LB PHARMACEUTICALS INC
PURCHASE
767$15.00$11.5K2,029Sep 12, 2025Sep 16, 2025View →
LBRX
LB PHARMACEUTICALS INC
PURCHASE
547,648547,648Sep 12, 2025Sep 16, 2025View →
LBRX
LB PHARMACEUTICALS INC
PURCHASE
1,2621,262Sep 12, 2025Sep 16, 2025View →
LBRX
LB PHARMACEUTICALS INC
PURCHASE
332,566$15.00$4.99M880,214Sep 12, 2025Sep 16, 2025View →
LBRX
LB PHARMACEUTICALS INC
SALE
30,6670Sep 12, 2025Sep 16, 2025View →
LBRX
LB PHARMACEUTICALS INC
SALE
13,302,6660Sep 12, 2025Sep 16, 2025View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
252,553$22.00$5.56M252,553Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
583$22.00$12.8K583Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
4,523,9244,523,924Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
4,401,7710Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
8,830,9010Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
7,356,1620Feb 12, 2024Feb 14, 2024View →
Other insiders · KYTX
Loading peer insiders…
About this filer
CIK 0001855502
ROLE
10% Owner
PRIMARY
KYTX
COMPANIES
2
ACTIVE SINCE
Feb 2024
MARKETPEEL · /INSIDER/0001855502DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback